NOACs differ with regard to bleeding risk

Non-vitamin K antagonist Oral Anticoagulants (NOACs) have become the mainstay therapy for stroke prophylaxis in atrial fibrillation. Although shown equally or more safe and effective than warfarin, there is limited knowledge of the comparative effectiveness and safety of the NOACs…. Read More ›

Stroke in athletes with atrial fibrillation

Network members Marius Myrstad, Trygve Berge, Håkon Ihle-Hansen, Eivind Sørensen and Marit Aarønæs have published a paper entitled Stroke in endurance athletes with atrial fibrillation in The European Journal of Preventive Cardiology. The researchers have investigated the association between atrial… Read More ›